SyVento is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. We specialize in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products, agricultural products as alternatives to synthetic pesticides and nanocarriers for cosmetics and dietary supplements.
Comprehensive services in the development of lipid-based nanocarriers and LNP technology.
Developing innovative, environmentally friendly liposomal formulations for fungicidal and herbicidal use in agriculture.
At SyVento BioTech, our state-of-the-art Biotechnology Research and Development Center in Europe stands as a testament to our commitment to pioneering global excellence in lipid-based nanocarrier and LNP technology.
Adhering to stringent cGMP quality standards, this facility is not merely an infrastructure but our window to the world, emphasizing our dedication to innovation and global collaboration.
Amplifying our global footprint each day, the center is our unwavering promise to partners worldwide, showcasing unmatched quality, safety, and a vision for collective success.
18 October 2023
SyVento BioTech Partners with Jagiellonian University’s FBBB for a Biotechnological Leap ForwardExciting developments are on the horizon! SyVento BioTech is proud to announce a partnership with the Faculty of Biochemistry, Biophysics, and...
9 October 2023
SyVento BioTech Welcomes Kajetan Bartosik as New CEOSyVento BioTech is delighted to announce the appointment of Kajetan Bartosik as its new Chief Executive Officer. With over 16 years...
27 September 2023
SyVento BioTech Participates in the Polish-British Future of Healthcare EventLONDON, September 26, 2023 – The Polish-British Future of Healthcare Event, focusing on advancements in MedTech, BioTech, and scientific research, will...
11 September 2023
SyVento BioTech Partners with LifeScience Kraków Cluster: A Global Vision with Local RootsSyVento BioTech Partners with LifeScience Kraków Cluster: A Global Vision with Local Roots In a strategic move that aims to consolidate our position...
31 August 2023
SyVento BioTech at the Forefront of RNA Therapeutics and Vaccines ConferenceIn an era where breakthroughs in RNA therapeutics are revolutionizing medicine, SyVento BioTech’s expertise in Lipid Nanoparticle (LNP) formulations stands out...
24 August 2023
SyVento BioTech at PHASE 2023 ConferenceSyVento BioTech at PHASE 2023 Conference The PHASE 2023 Conference stood as one of the most crucial discussions in the Polish...
1 August 2023
Reflecting on Our Participation in the 13th International Scientific Conference on AlkaptonuriaWe are proud to look back on our participation in the recently concluded 13th International Scientific Conference on Alkaptonuria (AKU) that...
6 June 2023
Aktualizacja Siedziby SyVento Sp. z o.o. / Change of Registered Office of SyVento sp. z o.o.Jest nam niezmiernie miło poinformować, że SyVento Sp. z o.o. z dniem 5 czerwca 2023 roku oficjalnie przenosi swoją siedzibę. Nowy adres wpisany...
6 June 2023
SyVento BioTech Attends BIO International Convention 2023SyVento BioTech Attends BIO International Convention 2023 SyVento BioTech is currently participating in the BIO International Convention 2023. The organization’s representatives...